OBJECTIVE: To evaluate whether Mohs surgeons' management of high-risk cutaneous squamous cell carcinoma (HRCSCC) is uniform regarding radiologic nodal staging (RNS) and adjuvant radiation therapy (ART). DESIGN: A survey study of randomly selected, fellowship-trained Mohs surgeons. SETTING: An academic medical center. PARTICIPANTS: American College of Mohs Surgery members who responded to an e-mail invitation completed either a survey regarding management of HRCSCC (n=117) or SCC with perineural invasion (PNI) (n=118). Participants totaled approximately 25% of the American College of Mohs Surgery membership. MAIN OUTCOME MEASURES: (1) Percentage of patients with HRCSCC referred for RNS, sentinel lymph node biopsy (SLNB), or ART over the preceding 12 months; (2) top factors leading surgeons to consider RNS, SLNB, or ART; and (3) acceptance of ART for clinical scenarios of various degrees of PNI. RESULTS: Most respondents cited PNI and in-transit metastasis as top factors leading to consideration of RNS, SLNB, or ART. Otherwise, there was no consensus regarding use of, or indications for, RNS, SLNB, or ART. CONCLUSIONS: The lack of consistency between experts indicates that there is equipoise regarding indications for RNS and ART in HRCSCC. There is also wide variation in RNS and ART practices among Mohs surgeons who are specifically trained to manage HRCSCC. Clinical trials should therefore be conducted in these areas as there is no clear standard of care.
OBJECTIVE: To evaluate whether Mohs surgeons' management of high-risk cutaneous squamous cell carcinoma (HRCSCC) is uniform regarding radiologic nodal staging (RNS) and adjuvant radiation therapy (ART). DESIGN: A survey study of randomly selected, fellowship-trained Mohs surgeons. SETTING: An academic medical center. PARTICIPANTS: American College of Mohs Surgery members who responded to an e-mail invitation completed either a survey regarding management of HRCSCC (n=117) or SCC with perineural invasion (PNI) (n=118). Participants totaled approximately 25% of the American College of Mohs Surgery membership. MAIN OUTCOME MEASURES: (1) Percentage of patients with HRCSCC referred for RNS, sentinel lymph node biopsy (SLNB), or ART over the preceding 12 months; (2) top factors leading surgeons to consider RNS, SLNB, or ART; and (3) acceptance of ART for clinical scenarios of various degrees of PNI. RESULTS: Most respondents cited PNI and in-transit metastasis as top factors leading to consideration of RNS, SLNB, or ART. Otherwise, there was no consensus regarding use of, or indications for, RNS, SLNB, or ART. CONCLUSIONS: The lack of consistency between experts indicates that there is equipoise regarding indications for RNS and ART in HRCSCC. There is also wide variation in RNS and ART practices among Mohs surgeons who are specifically trained to manage HRCSCC. Clinical trials should therefore be conducted in these areas as there is no clear standard of care.
Authors: Pritesh S Karia; Anokhi Jambusaria-Pahlajani; David P Harrington; George F Murphy; Abrar A Qureshi; Chrysalyne D Schmults Journal: J Clin Oncol Date: 2013-12-23 Impact factor: 44.544
Authors: Flora Yan; Brittny N Tillman; Rajiv I Nijhawan; Divya Srivastava; David J Sher; Vladimir Avkshtol; Jade Homsi; Justin A Bishop; Erin M Wynings; Rebecca Lee; Larry L Myers; Andrew T Day Journal: Ann Surg Oncol Date: 2021-06-30 Impact factor: 5.344
Authors: Matthew Fox; Marc Brown; Nicholas Golda; Dori Goldberg; Christopher Miller; Melissa Pugliano-Mauro; Chrysalyne Schmults; Thuzar Shin; Thomas Stasko; Yaohui G Xu; Kishwer Nehal Journal: J Am Acad Dermatol Date: 2018-09-15 Impact factor: 11.527
Authors: Sherri Borman; Jeff Wilkinson; Lauren Meldi-Sholl; Clare Johnson; Kelsey Carter; Kyle R Covington; Alison L Fitzgerald; Sarah J Kurley; Aaron S Farberg; Matthew S Goldberg; Federico A Monzon; Kristen Oelschlager; Robert W Cook Journal: Diagn Pathol Date: 2022-02-25 Impact factor: 2.644